Organization | Zambia-Emory HIV Research Project

Zambia-Emory HIV Research Project Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial

2005

NCT00888446

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Alternative names

Zambia-Emory HIV Research Project (ZEHRP), Lusaka

Active Ingredients

Drugs in Phase 2 Trials (3)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)

measles, mumps, and rubella vaccine (MMR) (1 trial)

tgaac09 (1 trial)

Drugs in Phase 1 Trials (2)

ad35-grin (1 trial)

ad35 investigational hiv vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acquired Immunodeficiency Syndrome (Phase 2)

Communicable Diseases (Phase 2)

HIV Infections (Phase 2)

Infections (Phase 2)

Virus Diseases (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 3
# of Trial APIs: 5